Gland Pharma Limited

NSEI:GLAND Stock Report

Market Cap: ₹284.7b

Gland Pharma Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Srinivas Sadu

Chief executive officer

₹123.6m

Total compensation

CEO salary percentage49.2%
CEO tenure5yrs
CEO ownershipn/a
Management average tenureless than a year
Board average tenure4.8yrs

Recent management updates

Recent updates

Is Gland Pharma (NSE:GLAND) A Risky Investment?

Mar 19
Is Gland Pharma (NSE:GLAND) A Risky Investment?

Gland Pharma Limited's (NSE:GLAND) Share Price Matching Investor Opinion

Feb 16
Gland Pharma Limited's (NSE:GLAND) Share Price Matching Investor Opinion

Analysts' Revenue Estimates For Gland Pharma Limited (NSE:GLAND) Are Surging Higher

May 20
Analysts' Revenue Estimates For Gland Pharma Limited (NSE:GLAND) Are Surging Higher

Is Gland Pharma Limited (NSE:GLAND) Expensive For A Reason? A Look At Its Intrinsic Value

Feb 07
Is Gland Pharma Limited (NSE:GLAND) Expensive For A Reason? A Look At Its Intrinsic Value

Analysts Just Slashed Their Gland Pharma Limited (NSE:GLAND) EPS Numbers

Jul 22
Analysts Just Slashed Their Gland Pharma Limited (NSE:GLAND) EPS Numbers

Does This Valuation Of Gland Pharma Limited (NSE:GLAND) Imply Investors Are Overpaying?

Jul 14
Does This Valuation Of Gland Pharma Limited (NSE:GLAND) Imply Investors Are Overpaying?

Is Now The Time To Put Gland Pharma (NSE:GLAND) On Your Watchlist?

Feb 08
Is Now The Time To Put Gland Pharma (NSE:GLAND) On Your Watchlist?

A Look At The Intrinsic Value Of Gland Pharma Limited (NSE:GLAND)

Jul 05
A Look At The Intrinsic Value Of Gland Pharma Limited (NSE:GLAND)

Gland Pharma (NSE:GLAND) Strong Profits May Be Masking Some Underlying Issues

May 24
Gland Pharma (NSE:GLAND) Strong Profits May Be Masking Some Underlying Issues

Gland Pharma Limited (NSE:GLAND) Exceeded Expectations And The Analyst Consensus Has Been Reviewing Its Models

May 19
Gland Pharma Limited (NSE:GLAND) Exceeded Expectations And The Analyst Consensus Has Been Reviewing Its Models

Gland Pharma Limited's (NSE:GLAND) 27% Price Boost Is Out Of Tune With Earnings

Mar 04
Gland Pharma Limited's (NSE:GLAND) 27% Price Boost Is Out Of Tune With Earnings

Gland Pharma Limited's (NSE:GLAND) Stock Is Going Strong: Is the Market Following Fundamentals?

Feb 20
Gland Pharma Limited's (NSE:GLAND) Stock Is Going Strong: Is the Market Following Fundamentals?

CEO Compensation Analysis

How has Srinivas Sadu's remuneration changed compared to Gland Pharma's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023n/an/a

₹7b

Sep 30 2023n/an/a

₹7b

Jun 30 2023n/an/a

₹7b

Mar 31 2023₹124m₹61m

₹8b

Dec 31 2022n/an/a

₹10b

Sep 30 2022n/an/a

₹10b

Jun 30 2022n/an/a

₹11b

Mar 31 2022₹124m₹61m

₹12b

Dec 31 2021n/an/a

₹12b

Sep 30 2021n/an/a

₹11b

Jun 30 2021n/an/a

₹10b

Mar 31 2021₹89m₹31m

₹10b

Dec 31 2020n/an/a

₹9b

Jun 30 2020n/an/a

₹9b

Mar 31 2020₹59m₹32m

₹8b

Mar 31 2019₹23mn/a

₹5b

Mar 31 2018₹11m₹5m

₹3b

Compensation vs Market: Srinivas's total compensation ($USD1.48M) is above average for companies of similar size in the Indian market ($USD539.04K).

Compensation vs Earnings: Srinivas's compensation has been consistent with company performance over the past year.

CEO

Srinivas Sadu (54 yo)

5yrs

Tenure

₹123,580,000

Compensation

Mr. Srinivas Sadu, B. Pharm, M. S., MBA, PG Certificate in Finance and Management, has been Managing Director and Chief Executive Officer at Gland Pharma Ltd. since April 25, 2019 and serves as its Executi...

Leadership Team

NamePositionTenureCompensationOwnership
Srinivas Sadu
MD, CEO & Executive Director5yrs₹123.58mno data
Ravi Mitra
Chief Financial Officer4.6yrs₹15.15mno data
Sampath Pallerlamudi
Company Secretary & Compliance Officerno data₹5.11mno data
Prakash Baliga
Chief Operating Officerless than a yearno data0.000010%
₹ 28.5k
Ankit Gupta
Vice President of Strategy & Investmentsless than a yearno datano data
Sumanta Bajpayee
Vice President of Investor Relationsno datano datano data
Surinder Koul
Head of Domestic Marketingless than a yearno datano data
Shilpi Sahay
Deputy General Manager of Human Resourcesno datano datano data
C. Venkatesan
Senior Vice President of R&Dno data₹11.35m0.0030%
₹ 8.7m
Surapanini Sridevi
Senior Vice President of R&Dno datano datano data
K Rao
Head of Qualityless than a yearno data0.0055%
₹ 15.5m
Rong Wu
Chief Financial Controllerno datano datano data

0.6yrs

Average Tenure

49yo

Average Age

Experienced Management: GLAND's management team is not considered experienced ( 0.6 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Srinivas Sadu
MD, CEO & Executive Director5yrs₹123.58mno data
Fang Yao
Non-Executive & Non- Independent Director2.1yrsno datano data
Naina Lal Kidwai
Independent Director2.9yrs₹10.40mno data
Udo Vetter
Independent Director6.2yrs₹2.90mno data
Jia Ai Zhang
Non-Independent Non Executive Director2.9yrsno datano data
Yiu Kwan Lau
Independent Chairman4.8yrs₹4.97mno data
Satyanarayana Chavali
Independent Director5.4yrs₹3.00mno data
Chen Qiyu
Non-Executive & Non-Independent Director6.5yrsno datano data
Essaji Vahanvati
Independent Director3.6yrs₹2.90mno data

4.8yrs

Average Tenure

62yo

Average Age

Experienced Board: GLAND's board of directors are considered experienced (4.8 years average tenure).

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.